News
Low folate levels in pregnant women may be linked to hyperactive children
30 April 2010
Attention-deficit and hyperactivity problems in children may be associated with low vitamin B9 (folate) levels during pregnancy, suggests a new UK study.
20 October 2011
Hohenheim Nutrition Information, Institute of Biological Chemistry and Nutrition Science, Hohenheim University, Germany
“In 2009, Kyong Park and colleagues published a study of more than 40,000 women taking part in the Iowa Women's Health Study, whom they had interviewed over a period of 19 years with questionnaires on the consumption of vitamin and mineral supplements (1). They came to the conclusion that the use of dietary supplements among older people was especially positive because reduced nutrient intake, likely as a result of reduced food intake in old age, could be compensated.
So it was all the more surprising that the same authors came to an astonishing new conclusion with a recently published re-evaluation of the study participants’ data. In this study (2) the authors conclude that older women who take dietary supplements have a higher risk of death. This, according to the authors, is especially the case with iron supplements and multivitamin/mineral preparations. At the same time, the authors saw a reduced risk of death in women who took calcium supplements. The study period extended over 22 years and, at the beginning (1986), covered 38,772 middle-age women of 61.5 years, 24,329 of whom reported using a dietary supplement – without stating the exact dose or the reasons for taking it (preventative, therapeutic, etc.) – and 14,443 of whom said they did not. By the closing date of 31.12.2008, a total of 15,594 (40.2%) of the women had died.
According to the authors, the consumption of multivitamin/mineral preparations increased the mortality rate among older women by 2.4%, supplements containing copper increased mortality by 18%, and calcium supplementation reduced mortality by 3.8%. For all other dietary supplements, even iron, there were no statistically significant differences shown in the end.
How can the observed or described increase in mortality be explained?
It turns out that it’s possible to influence the results as desired by using different adjustment methods. The authors provide the best evidence for this: by arbitrarily choosing which factors to consider, these could ultimately reduce or increase the risk of death for individual dietary supplements. For those women who took B-complex vitamins, as well as vitamins C, E and D and calcium, mortality was at first significantly lower. After adjustment of the data, the significance largely disappeared, remaining only for calcium. Only after a further adjustment was the mortality increase result obtained.
Overall, there are no scientifically accurate data to be gleaned in this study that could support the conclusion of the study that the intake of dietary supplements shortens life.
On the basis of various studies, which are also mentioned by the authors, it is apparent that in the case of older persons in particular, quality of life increases with the intake of multivitamin/mineral supplements or various dietary supplements (especially vitamin D), and that these have little influence on mortality. That said, it is just the study itself, driven by unclear motivations, that must be scrutinized. We should ask ourselves to what extent the conclusion, which is unhelpful for older people (among whom a high percentage of deficiency has been detected), is leading us astray.
The same applies to a comment (3) explaining that antioxidants such as those found in dietary supplements were known to increase mortality. As evidence, it cites three studies that only suggested this for long-term use of high-dose supplements (of ten times or more of the recommended daily dose). The commentator also notes that the use of vitamin and mineral supplements cannot be recommended for a population already sufficiently supplied with micronutrients. This is a scientific consensus. However, the group covered in the current study is composed of older participants and it can be assumed, based on a variety of data, that the declining food intake of older people no longer meets qualitative requirements (micronutrient content).
It must be maintained that the results of the current study (2) are implausible and unhelpful for discussing the problems of malnutrition because the terse statement that dietary supplements are dangerous is itself not very helpful and may alarm those whom it potentially concerns. After critical examination of the work the uncomfortable feeling remains that the authors, much like the journal that took on the publication of this work, wanted to exploit a negative message to increase the importance of the study.”
Hohenheim, October 2011
30 April 2010
Attention-deficit and hyperactivity problems in children may be associated with low vitamin B9 (folate) levels during pregnancy, suggests a new UK study.
1 January 2013
Humans require an adequate intake of micronutrients in order to maintain normal bodily function. Though it is possible to obtain sufficient doses from a healthy diet, proper micronutrient nutrition is not always possible, especially in low- and middle-income countries. In developed countries, national intake surveys have shown inadequate micronutrient status for vulnerable population groups, such as children, women during pregnancy and lactation, the elderly, and people who are ill, as well as for young to middle-aged adults who make unhealthy food and other lifestyle-related choices that become risk factors. Micro-nutrient deficiencies and long-term insufficient intakes are associated with adverse health effects ranging from severe birth defects to chronic diseases. The costs of treating these health implications, as well as the productivity lost due to micronutrient deficiency-related morbidity and mortality, have been found in various studies to be economically significant. Interventions aimed at correcting insufficient micronutrient intakes have been generally proven cost effective.
9 November 2015
Low serum vitamin D levels are common in sufferers of the painful condition rheumatoid arthritis. This condition is caused by inflammation. Vitamin D has beneficial immunomodulatory effects, so even low dose supplementation could enable the dose of conventional rheumatoid arthritis therapies to be reduced, with the consequent benefit of a reduction in side effects. A very recent trial supports this hypothesis.